On October 9, 2008, Les Affaires titled "Biotechs on the verge of extinction". According to the article, Quebec biotechnology companies own two and a half times less capital than their counterparts in the rest of Canada. Less than two years later, the biopharmaceutical sector in Quebec is at the top of venture capital investment, with $38 million financing seven Quebec companies in the second quarter of 2010 (Chaurette and Béïque, 2010). Will this influx of money succeed in pulling the industry out of its slump?